The burden and management of cytochrome P450 2D6 (CYP2D6)-mediated drug-drug interaction (DDI): co-medication of metoprolol and paroxetine or fluoxetine in the elderly. (Q36323469)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	The burden and management of cytochrome P450 2D6 (CYP2D6)-mediated drug-drug interaction (DDI): co-medication of metoprolol and paroxetine or fluoxetine in the elderly.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28345306%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

The burden and management of cytochrome P450 2D6 (CYP2D6)-mediated drug-drug interaction (DDI): co-medication of metoprolol and paroxetine or fluoxetine in the elderly (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28345306%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

1 reference

based on heuristic

inferred from title

drug interaction

1 reference

based on heuristic

inferred from title

Muh Akbar Bahar

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28345306%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

author name string

Eelko Hak

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28345306%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

Jens H J Bos

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28345306%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

Sander D Borgsteede

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28345306%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

Bob Wilffert

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28345306%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

language of work or name

1 reference

based on heuristic

inferred from title

publication date

26 March 2017

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28345306%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

Pharmacoepidemiology and Drug Safety

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28345306%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

26

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28345306%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28345306%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

752-765

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28345306%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

The prevalence of co-prescription of clinically relevant CYP enzyme inhibitor and substrate drugs in community-dwelling elderly Australians.

1 reference

https://api.crossref.org/works/10.1002%2FPDS.4200

21 January 2018

Hospital admissions/visits associated with drug-drug interactions: a systematic review and meta-analysis.

1 reference

https://api.crossref.org/works/10.1002%2FPDS.4200

21 January 2018

Potential for drug interactions involving cytochromes P450 2D6 and 3A4 on general adult psychiatric and functional elderly psychiatric wards.

1 reference

https://api.crossref.org/works/10.1002%2FPDS.4200

21 January 2018

Age- and gender-specific prevalence of depression in latest-life--systematic review and meta-analysis.

1 reference

https://api.crossref.org/works/10.1002%2FPDS.4200

21 January 2018

Quality of life of elderly people living in a retirement home

1 reference

https://api.crossref.org/works/10.1002%2FPDS.4200

21 January 2018

Drug-related problems vary with medication category and treatment duration in Taiwanese heart failure outpatients receiving case management.

1 reference

https://api.crossref.org/works/10.1002%2FPDS.4200

21 January 2018

Effects of metoprolol CR/XL on mortality and hospitalizations in patients with heart failure and history of hypertension

1 reference

https://api.crossref.org/works/10.1002%2FPDS.4200

21 January 2018

Metoprolol controlled release/extended release in patients with severe heart failure: analysis of the experience in the MERIT-HF study

1 reference

https://api.crossref.org/works/10.1002%2FPDS.4200

21 January 2018

A metoprolol-terbinafine combination induced bradycardia

1 reference

https://api.crossref.org/works/10.1002%2FPDS.4200

21 January 2018

A meta-analysis of CYP2D6 metabolizer phenotype and metoprolol pharmacokinetics

1 reference

https://api.crossref.org/works/10.1002%2FPDS.4200

21 January 2018

Paroxetine affects metoprolol pharmacokinetics and pharmacodynamics in healthy volunteers

1 reference

https://api.crossref.org/works/10.1002%2FPDS.4200

21 January 2018

Increased frequency of cytochrome P450 2D6 poor metabolizers among patients with metoprolol-associated adverse effects

1 reference

https://api.crossref.org/works/10.1002%2FPDS.4200

21 January 2018

Depression and cardiovascular disease: mechanisms of interaction

1 reference

https://api.crossref.org/works/10.1002%2FPDS.4200

21 January 2018

Depression and myocardial infarction: relationship between heart and mind

1 reference

https://api.crossref.org/works/10.1002%2FPDS.4200

21 January 2018

Treatment of depression in cardiovascular disease

1 reference

https://api.crossref.org/works/10.1002%2FPDS.4200

21 January 2018

Inhibition of metoprolol metabolism and potentiation of its effects by paroxetine in routinely treated patients with acute myocardial infarction (AMI).

1 reference

https://api.crossref.org/works/10.1002%2FPDS.4200

21 January 2018

Antidepressants, metoprolol and the risk of bradycardia

1 reference

https://api.crossref.org/works/10.1002%2FPDS.4200

21 January 2018

CYP2D6 inhibition by fluoxetine, paroxetine, sertraline, and venlafaxine in a crossover study: intraindividual variability and plasma concentration correlations

1 reference

https://api.crossref.org/works/10.1002%2FPDS.4200

21 January 2018

The impact of paroxetine coadministration on stereospecific carvedilol pharmacokinetics.

1 reference

https://api.crossref.org/works/10.1002%2FPDS.4200

21 January 2018

Detection and prevention of drug-drug interactions in the hospitalized elderly: utility of new cytochrome p450-based software

1 reference

https://api.crossref.org/works/10.1002%2FPDS.4200

21 January 2018

A critical evaluation of clinical decision support for the detection of drug-drug interactions

1 reference

https://api.crossref.org/works/10.1002%2FPDS.4200

21 January 2018

Drug safety alert generation and overriding in a large Dutch university medical centre

1 reference

https://api.crossref.org/works/10.1002%2FPDS.4200

21 January 2018

Turning off frequently overridden drug alerts: limited opportunities for doing it safely

1 reference

https://api.crossref.org/works/10.1002%2FPDS.4200

21 January 2018

Pharmacy data in epidemiological studies: an easy to obtain and reliable tool

1 reference

https://api.crossref.org/works/10.1002%2FPDS.4200

21 January 2018

Angiotensin-converting enzyme inhibitor treatment and the development of urinary tract infections: a prescription sequence symmetry analysis

1 reference

https://api.crossref.org/works/10.1002%2FPDS.4200

21 January 2018

Does a cardiovascular event change adherence to statin treatment in patients with type 2 diabetes? A matched cohort design

1 reference

https://api.crossref.org/works/10.1002%2FPDS.4200

21 January 2018

P-Glycoprotein-Mediated Drug Interactions in Pregnancy and Changes in the Risk of Congenital Anomalies: A Case-Reference Study.

1 reference

https://api.crossref.org/works/10.1002%2FPDS.4200

21 January 2018

Unjustified prescribing of CYP2D6 inhibiting SSRIs in women treated with tamoxifen

1 reference

https://api.crossref.org/works/10.1002%2FPDS.4200

21 January 2018

Differential effects of nebivolol versus metoprolol on functional sympatholysis in hypertensive humans

1 reference

https://api.crossref.org/works/10.1002%2FPDS.4200

21 January 2018

Influence of the CYP2D6*4 polymorphism on dose, switching and discontinuation of antidepressants

1 reference

https://api.crossref.org/works/10.1002%2FPDS.4200

21 January 2018

Two separate dose-dependent effects of paroxetine: mydriasis and inhibition of tramadol's O-demethylation via CYP2D6.

1 reference

https://api.crossref.org/works/10.1002%2FPDS.4200

21 January 2018

The economic consequences of a drug-drug interaction

1 reference

https://api.crossref.org/works/10.1002%2FPDS.4200

21 January 2018

Co-prescription of cytochrome P450 2D6/3A4 inhibitor-substrate pairs in clinical practice. A retrospective analysis of data from Norwegian primary pharmacies.

1 reference

https://api.crossref.org/works/10.1002%2FPDS.4200

21 January 2018

Physicians' decisions to override computerized drug alerts in primary care

1 reference

https://api.crossref.org/works/10.1002%2FPDS.4200

21 January 2018

Influence of metoprolol dosage release formulation on the pharmacokinetic drug interaction with paroxetine

1 reference

https://api.crossref.org/works/10.1002%2FPDS.4200

21 January 2018

Nationwide drug-dispensing data reveal important differences in adherence to drug label recommendations on CYP2D6-dependent drug interactions

1 reference

https://api.crossref.org/works/10.1002%2FPDS.4200

21 January 2018

CYP2D6 status of extensive metabolizers after multiple-dose fluoxetine, fluvoxamine, paroxetine, or sertraline

1 reference

https://api.crossref.org/works/10.1002%2FPDS.4200

21 January 2018

Atenolol in hypertension: is it a wise choice?

1 reference

https://api.crossref.org/works/10.1002%2FPDS.4200

21 January 2018

CYP2D6 is a major determinant of metoprolol disposition and effects in hospitalized Russian patients treated for acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1002%2FPDS.4200

21 January 2018

Overriding of drug safety alerts in computerized physician order entry

1 reference

https://api.crossref.org/works/10.1002%2FPDS.4200

21 January 2018

Pharmacist-based medication review reduces potential drug-related problems in the elderly: the SMOG controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FPDS.4200

21 January 2018

Identification of drug-related problems by a clinical pharmacist in addition to computerized alerts.

1 reference

https://api.crossref.org/works/10.1002%2FPDS.4200

21 January 2018

Interaction of metoprolol and fluoxetine

1 reference

https://api.crossref.org/works/10.1002%2FPDS.4200

21 January 2018

Identifiers

10.1002/PDS.4200

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28345306%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28345306%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36323469&oldid=1636122168"